Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Leukemia Research|January 3, 2012
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)M Mansour Ceesay, Estella Matutes, Graham P Taylor, et al.
Cancer Immunology, Immunotherapy : CII|February 2, 2006
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemiaLucas Chan, Nicola R Hardwick, Barbara-ann Guinn, et al.
Nature Communications|December 9, 2015
SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartmentSyed A Mian, Kevin Rouault-Pierre, Alexander E Smith, et al.
Leukemia Research|December 6, 2011
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshopUwe Platzbecker, Valeria Santini, Ghulam J Mufti, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Development of a whole cell vaccine for acute myeloid leukaemiaAdam T C Cheuk, Lucas Chan, Barbara Czepulkowski, et al.
The Journal of Infection|June 30, 2006
Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantationZiYi Lim, Bob Baker, Mark Zuckerman, et al.
Biochemical and Biophysical Research Communications|August 23, 2005
Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemiaBarbara-Ann Guinn, Elizabeth A Bland, Usman Lodi, et al.
Haematologica|November 4, 2005
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donorsBronwen E Shaw, Nigel H Russell, Steve Devereux, et al.
Haematologica|June 4, 2009
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumabKatie Matthews, ZiYi Lim, Behdad Afzali, et al.
Health and Quality of Life Outcomes|September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patientsAgota Szende, Caroline Schaefer, Thomas F Goss, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Leukemia Research|January 3, 2012
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)M Mansour Ceesay, Estella Matutes, Graham P Taylor, et al.
Cancer Immunology, Immunotherapy : CII|February 2, 2006
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemiaLucas Chan, Nicola R Hardwick, Barbara-ann Guinn, et al.
Nature Communications|December 9, 2015
SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartmentSyed A Mian, Kevin Rouault-Pierre, Alexander E Smith, et al.
Leukemia Research|December 6, 2011
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshopUwe Platzbecker, Valeria Santini, Ghulam J Mufti, et al.
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Development of a whole cell vaccine for acute myeloid leukaemiaAdam T C Cheuk, Lucas Chan, Barbara Czepulkowski, et al.
The Journal of Infection|June 30, 2006
Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantationZiYi Lim, Bob Baker, Mark Zuckerman, et al.
Biochemical and Biophysical Research Communications|August 23, 2005
Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemiaBarbara-Ann Guinn, Elizabeth A Bland, Usman Lodi, et al.
Haematologica|November 4, 2005
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donorsBronwen E Shaw, Nigel H Russell, Steve Devereux, et al.
Haematologica|June 4, 2009
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumabKatie Matthews, ZiYi Lim, Behdad Afzali, et al.
Health and Quality of Life Outcomes|September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patientsAgota Szende, Caroline Schaefer, Thomas F Goss, et al.
Pageof 23